Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of Renal Autologous Cell Therapy (REACT®) in Type 2 Diabetics With Chronic Kidney Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02836574
Recruitment Status : Active, not recruiting
First Posted : July 19, 2016
Last Update Posted : February 15, 2022
CTI Clinical Trial and Consulting Services
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : May 2025
Estimated Study Completion Date : May 2028